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Abstract Integrin-linked kinase (ILK) is a scaffolding
protein with central roles in tissue development and homeostasis. Much debate has focused on whether ILK is a bona fide
or a pseudo- kinase. This aspect of ILK function has been
complicated by the large volumes of conflicting observations
obtained from a wide variety of experimental approaches,
from in vitro models, to analyses in invertebrates and in
mammals. Key findings in support or against the notion that
ILK is catalytically active are summarized. The importance of
ILK as an adaptor protein is well established, and defining its
role as a signaling hub will be the next key step to understand
its distinct biological roles across tissues and species.
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Abbreviations
ECM Extracellular matrix
GST Glutathione-S-transferase
ILK
Integrin-linked kinase
PH
Pleckstrin homology

The interactions between cells and their surrounding ECM
play key roles in normal tissue homeostasis, and their
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disruption is involved in the pathogenesis of numerous
human disorders. Cell adhesion to the ECM is mediated by
integrins (Hynes, 2002) and other transmembrane proteins.
Unlike many other types of receptors, integrins have no
intrinsic signaling or catalytic properties. Cellular responses
to ECM stimuli require the recruitment to sites of integrin
clustering of cytoplasmic adaptor proteins. The latter,
together with integrins, form multiprotein complexes
termed focal adhesions, which allow the initiation of a
variety of signaling cascades (Legate et al., 2009). In
particular, the association of integrins with ILK regulates
important aspects of cell function, including attachment to
the ECM, acquisition of front-rear polarity, migration,
survival and transformation (McDonald et al., 2008). The
importance of ILK is abundantly clear, as it is indispensable
for the development and/or function of every tissue
examined to-date, ranging from bone and cartilage, to
cardiovascular, hematopoietic and nervous systems, liver,
kidney, skeletal muscle and skin (Wickstrom et al., 2010).
ILK was identified over a decade ago, and was widely
recognized as a bona fide kinase for several years, until
studies in invertebrate and mammalian systems indicated
that structural alterations that degraded its catalytic properties had no effect on its biological activity (Mackinnon et
al., 2002; Sakai et al., 2003; Zervas et al., 2001). From
those key reports, ILK was defined as an important hub for
protein-protein interactions, rather than a kinase, triggering
a flurry of efforts that have continued for a decade, focused
on addressing this contention. As a result, and aside from
the considerable volume of conflicting information that has
been generated, the notion that ILK plays important
scaffold roles in multiple tissues and organs has been
reinforced.
ILK was identified as an integrin β1-interacting protein
in a yeast two-hybrid screen (Hannigan et al., 1996). In
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silico analysis of its amino acid sequence indicated the
existence of 4 putative ankyrin repeats at its N-terminus, a
central PH domain, and a C-terminal region with high, but
imperfect homology to bona fide kinase domains. However,
significant departures from the in silico predictions have
become apparent from crystallographic studies, resulting in
the identification of not four, but five ankyrin repeats, and
the observation that the predicted PH motif may not
functionally exist, as this region cannot bind PIP3 (Chiswell
et al., 2010; Fukuda et al., 2009). Given the importance of
ILK, a substantial body of work has focused on two aspects
that to-date remain highly controversial: The kinase properties of ILK, and its potential as a general therapeutic target.
Structural analyses of full-length ILK have yet to be
reported. However, detailed crystallographic studies of the
ILK C-terminal putative kinase domain (amino acid
residues 183–452) bound to the CH2 region of α-parvin
have been conducted (Fukuda et al., 2009). In this complex,
the ILK kinase domain exhibits an overall structure that
strongly resembles that of other kinases, including its
ability to bind ATP. However, under these conditions, the
kinase domain does not catalyze ATP hydrolysis, which is
an essential step for kinase function. It has been subsequently suggested that the lack of ILK kinase activity in
α-parvin-containing complexes may arise from the fact that
the latter acts as a negative regulator of ILK (Maydan et al.,
2010). However, this observation contrasts with previous
reports that α-parvin interactions with ILK actually
stimulate its activity, at least in the context of ILK
immunoprecipitates isolated from DU145 cells (Attwell et
al., 2003). Other important features that diverge in the ILK
kinase domain include the deletion or substitution of residues
that are key for catalytic activity in other kinases (Fukuda et
al., 2009). Thus, although sequence-based analyses predict
reasonable homology of the ILK kinase C-terminus with
other kinases, 3D structural characterization indicates that the
divergence is important enough to preclude catalytic activity,
at least when bound to the α-parvin CH2 domain.
In vitro assays to examine the kinase properties of ILK
have also yielded conflicting results. Thus, whereas a
bacterially produced GST-ILK fusion protein purified by
denaturing polyacrylamide gel electrophoresis was reported
to phosphorylate myelin basic protein (Hannigan et al.,
1996), neither full-length bacterially produced ILK purified
from a complex containing the LIM 1–2 domain of PINCH,
nor recombinant, commercial ILK exhibited any measurable kinase activity (Fukuda et al., 2009). More recently,
studies with baculovirus-produced ILK isolated to about
94% purity showed in vitro phosphorylation of a GSK-3β
substrate peptide, of LC20 and of ILK itself, although no
information regarding Akt, another putatitve ILK substrate,
was reported (Maydan et al., 2010). Kinase activity in these
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assays was greater in the presence of Mn2+ relative to Mg2+.
The reasons why these approaches show ILK kinase activity
in some cases and not in others remain undefined. It is
possible that the isolation procedures for the bacterially
purified proteins resulted in their denaturation and loss of
activity. Given that bacterially purified ILK was originally
reported to have kinase properties, the need for posttranslational modifications would appear not to play a
substantial role. On the other hand, it is also possible that
even low levels of contaminating proteins in the baculovirus
preparations may have contributed to the catalytic activity
reported.
A vast number of investigators have isolated ILK
immunoprecipitates from a variety of vertebrate cells and
tissues, and demonstrated the presence of kinase activity in
these multiprotein complexes (Attwell et al., 2003; Deng et
al., 2001a; Lange et al., 2009). These studies have focused
on both endogenous and exogenously expressed ILK, and
have reported that ILK-containing immune complexes have
the capacity to phosphorylate various physiological substrates, including Akt, GSK-3β, LC20, and myosin phosphatase (Delcommenne et al., 1998; Deng et al., 2001b;
Kiss et al., 2002; Muranyi et al., 2002). In spite of the
compelling evidence in support of the presence of kinase
activities in ILK-containing complexes, the role of ILK
itself in Akt phosphorylation remains unclear. Thus,
whereas ILK inactivation by genetic or pharmacological
means reportedly results in reduced Akt phosphorylation in
a variety of cell lines and tissues, such as IEC-18 intestinal
epithelial cells, HEK 293 human embryonic kidney cells
(Delcommenne et al., 1998), in Schwann cells of the
peripheral nervous system (Pereira et al., 2009), and in
cardiomyocytes (White et al., 2006), similar interventions
do not affect Akt phosphorylation in immortalized kidney
fibroblasts (Sakai et al., 2003), chondrocytes (Grashoff et
al., 2003) or primary epidermal keratinocytes (Lorenz et
al., 2007). Given the scaffolding properties of ILK and the
variety of proteins with which it interacts, the presence of
kinase activity in ILK immune complexes is not unexpected. However, based on current evidence, it would
appear that the modulating role of ILK-containing species
vis-à-vis Akt may be cell- and/or context-dependent.
The consequences of disrupting residues considered key
for ILK kinase function have been recently explored in vivo
(Lange et al., 2009), reiterating the complexity of ILK and
the fact that, in spite of its generalized role in actin
cytoskeletal dynamics and cell adhesion, it also fulfills
tissue-specific functions. Specifically, mutation of K220 to
either A or M, which abrogates interactions with α-parvin,
resulted in embryonic or perinatal lethality due to impaired
kidney morphogenesis. These defects were attributed to
alterations in actin dynamics and cell interactions with the
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ECM. On the basis of the similar phenotype observed in
α-parvin-deficient mice, it was proposed that the altered
kidney development in mice expressing ILK K220A or
K220M was likely caused by altered α-parvin localization
and function, rather than by the loss of ILK kinase activity.
Additional studies showing that inactivation of α-parvin in
a mouse background expressing ILK K220A result in the
same phenotypic alterations as those observed in the single
mutants would strengthen this hypothesis, as alterations
independent of α-parvin function may also be involved.
Significantly, although the K220A mutation had been
previously reported to abolish kinase activity (Filipenko et
al., 2005; Yamaji et al., 2001), in vitro measurements of
baculovirus-produced ILK K220A reported alterations in
the kinetics of GSK-3β peptide phosphorylation, reducing
the Vmax for this reaction to about 40% of the wild type
protein (Maydan et al., 2010). The reasons for these
inconsistencies are unclear. However, if the altered nephrogenesis in mice expressing ILK K220A involves reduced
kinase activity, this would imply the existence of important,
as yet uncharacterized dosage effects, in addition to the
established role of ILK scaffolds in this tissue.
In spite of the large volume of conflicting information
concerning whether and/or where ILK functions as a
kinase, it is clear that ILK fulfills key functions through
its scaffolding properties, albeit in tissue- and/or contextspecific manner. The existence of kinase activity associated
with ILK immune complexes isolated from a variety of
sources has been widely demonstrated. Establishing how
the scaffolding properties of ILK contribute to the recruitment of other signaling proteins, and defining the full
biological significance of these signaling platforms will be
a critical area for future research.
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